Last Updated: 08 Nov 2024
Executive Summary
STERIS plc (STE) is a leading provider of sterilization and surgical products for the US healthcare system. The company has a strong financial performance, with consistent revenue growth and profitability. The stock is currently trading at $215.5, below its 52-week high of $248.24. Analysts have a positive outlook on the stock, with a consensus target price of $251.59.
Company Overview
STERIS plc is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. The company's products are used in a variety of settings, including hospitals, clinics, and ambulatory surgery centers. STERIS plc has a global presence, with operations in over 50 countries.
Fundamental Analysis
STERIS plc has a strong financial performance. The company's revenue has grown steadily in recent years, from $4.5 billion in 2019 to $5.3 billion in 2022. The company's net income has also grown steadily, from $655 million in 2019 to $832 million in 2022.
The company's profitability is also strong. The company's gross profit margin has averaged 40% over the past five years. The company's operating profit margin has averaged 16% over the past five years. The company's net profit margin has averaged 10% over the past five years.
The company's balance sheet is also strong. The company has a low level of debt and a high level of cash on hand. The company's current ratio is 1.5, which is above the industry average. The company's debt-to-equity ratio is 0.5, which is below the industry average.
Technical Analysis
The stock price of STERIS plc has been trending higher in recent months. The stock price is currently trading above its 50-day moving average and its 200-day moving average. The stock price is also trading above its support level at $210. The stock price is likely to continue to trend higher in the short term.
Short Term Outlook
The short-term outlook for STERIS plc is positive. The company is expected to continue to benefit from the growing demand for its products. The company is also expected to benefit from the continued expansion of its global operations. The stock price is likely to continue to trend higher in the short term.
Long Term Outlook
The long-term outlook for STERIS plc is also positive. The company is expected to continue to benefit from the growing demand for its products. The company is also expected to benefit from the continued expansion of its global operations. The stock price is likely to continue to trend higher in the long term.
Analyst Recommendations
Analysts have a positive outlook on STERIS plc. The consensus target price for the stock is $251.59, which is above the current stock price of $215.5. Two analysts have a strong buy rating on the stock, two analysts have a buy rating on the stock, and four analysts have a hold rating on the stock. No analysts have a sell rating or a strong sell rating on the stock.
